Previous 10 | Next 10 |
2023-11-15 09:55:46 ET More on Sigyn Therapeutics, Inc. Financial information for Sigyn Therapeutics, Inc. For further details see: Sigyn Therapeutics Inc GAAP EPS of -$0.02
SAN DIEGO, CA . - ( NewMediaWire ) - November 14, 2023 - via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announces financial results for the third quarte...
SAN DIEGO, CA - ( NewMediaWire ) - October 04, 2023 - Sigyn Therapeutics, Inc. ( “ Sigyn” or the “ Company”) (OTCQB: SIGY), a development-stage medical technology company, today disclosed the submission of a Patent Cooperation Treaty (PCT) a...
SAN DIEGO, CA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today disclosed the submission of a Patent Cooperation Treaty (PCT) applicati...
SAN DIEGO, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a medical technology company that creates blood purification devices to overcome clearly defined limitations in healthcare, today announces financial res...
NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the OTCQB Venture Virtual Investor Conference, held on August 3 rd are now available for online viewing. REGISTER NOW AT...
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the OTCQB Venture Virtual Investor Conference. Individual investors, institutional investors, advisors, and analysts are invited to attend. ...
SAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:SIGY), a development-stage company that creates therapeutic blood purification candidates to overcome clearly defined limitations in healthcare, today announced that...
SAN DIEGO, CA - ( NewMediaWire ) - May 17, 2023 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, disclosed today that it has submitted a provisional patent application entitled: “ DEVICES ...
SAN DIEGO, CA, May 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, disclosed today that it has submitted a provisional patent application entitle...
News, Short Squeeze, Breakout and More Instantly...
Sigyn Therapeutics Inc Company Name:
SIGY Stock Symbol:
OTCMKTS Market:
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the company reported a loss from operations of $629,972, as compared to an operating loss of $521,258 for the compar...
SAN DIEGO, CA - ( NewMediaWire ) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the C...
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced that it has published an article entitled: “Sigyn Therapy(TM), an Emerging Candidate to Address Endotoxemia, Sepsis and Drug-Resistant Viral & Bacterial Infections.” “Wh...